This review explores the synergistic roles of virulence genes and antimicrobial resistance in pathogens, highlighting their clinical impact.
The emergence of (MDR) pathogens is a global public health crisis, posing significant challenges to effective treatment. Virulence genes and resistance determinants often co-exist in pathogens, influencing their pathogenic potential and survival. This review systematically explores the interaction between virulence factors and antimicrobial resistance genes, emphasizing their synergistic and antagonistic roles in pathogenicity and treatment outcomes. Using databases such as PubMed, Scopus, and Web of Science, we reviewed studies published over the past decade, with a focus on clinically relevant bacterial species. Our findings reveal a complex interplay that enhances bacterial fitness, evades host defenses, and limits therapeutic options. Understanding these interactions is critical for developing effective control strategies and novel therapeutics.
No takes yet. Share an insight, caveat, or question.
Sule et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: